Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
Ebola: The making of a $1 billion drug
CNN Money
Tue, 10/28/14 - 10:29 am
ebola virus
GSK
NewLink Genetics
JNJ
government contracts
Bavarian Nordic
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Mon, 10/27/14 - 03:25 pm
Merck
Gilead Sciences
hepatitis C
Sovaldi
JNJ
Olysio
Johnson & Johnson Wins First Pinnacle Hip Implant Trial
Bloomberg
Thu, 10/23/14 - 05:28 pm
JNJ
Pinnacle Hip
devices
hip implants
J&J, GSK ready to collaborate on Ebola vaccine work
Yahoo/Reuters
Wed, 10/22/14 - 07:57 am
JNJ
GSK
ebola virus
vaccines
J&J Says 250,000 Ebola Vaccine Doses to Be Ready by May
Bloomberg
Wed, 10/22/14 - 07:56 am
JNJ
vaccines
ebola virus
Janssen
Bavarian Nordic
J&J Ignored Reports Pinnacle Hip Implants Failed: Lawyer
Bloomberg
Tue, 10/21/14 - 04:31 pm
JNJ
Pinnacle Hip
hip implants
3 Drugs Critical to Johnson & Johnson's Future
Motley Fool
Tue, 10/21/14 - 09:20 am
JNJ
Olysio
Zytiga
Invega Sustenna
Xarelto
Stelara
Ebola Vaccine Trials Carry Risks for Companies in Chase
Bloomberg
Tue, 10/21/14 - 08:12 am
ebola virus
vaccines
GSK
JNJ
NewLink Genetics
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
Mon, 10/20/14 - 08:30 am
JNJ
Gilead Sciences
Olysio
hepatitis C
Sovaldi
J&J hikes 2014 forecast for a third time
Yahoo/AP
Tue, 10/14/14 - 01:08 pm
JNJ
Johnson & Johnson shares gain after profit beat, raised outlook
Marketwatch
Tue, 10/14/14 - 08:00 am
JNJ
earnings
What to expect from Johnson & Johnson’s earnings
Marketwatch
Mon, 10/13/14 - 08:33 am
JNJ
earnings
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Thu, 10/2/14 - 09:34 am
Celgene
Novartis
Eli Lilly
JNJ
Bristol-Myers Squibb
Biogen Idec
How Will Johnson & Johnson (JNJ) Stock Be Affected by This Acquisition?
TheStreet.com
Tue, 09/30/14 - 09:57 am
JNJ
M&A
Alios BioPharma
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma
Marketwatch
Tue, 09/30/14 - 08:47 am
JNJ
M&A
Alios BioPharma
J&J’s Exit from Morcellator Sales Leaves Opportunities for Others
WSJ Online
Tue, 09/23/14 - 04:54 pm
JNJ
laparoscopic power morcellators
Key Pharma Events For the Week Ahead
Bidness Etc.
Mon, 09/22/14 - 03:47 pm
Celgene
Otezla
CHMP
Gilead Sciences
Roche
Novartis
Merck
Eli Lilly
JNJ
GSK
Sanofi
Teva
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas
Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Mon, 09/22/14 - 08:37 am
Gilead Sciences
JNJ
Pharmacyclics
Imbruvica
Zydelig
Lawyer grills DePuy executive over safety studies for Pinnacle hips
Yahoo/Reuters
Tue, 09/16/14 - 09:22 am
JNJ
DePuy
Pinnacle Hip
devices
Pages
« first
‹ previous
…
97
98
99
100
101
102
103
104
105
…
next ›
last »